Cargando…

Structure-Activity Investigations and Optimisations of Non-metabolite Agonists for the Succinate Receptor 1

The succinate receptor 1 (SUCNR1) is a receptor for the metabolite succinate, which functions as a metabolic stress signal in the liver, kidney, adipose tissue and the retina. However, potent non-metabolite tool compounds are needed to reveal the physiological role and pharmacological potential of S...

Descripción completa

Detalles Bibliográficos
Autores principales: Rexen Ulven, Elisabeth, Trauelsen, Mette, Brvar, Matjaz, Lückmann, Michael, Bielefeldt, Line Ø., Jensen, Lisa K. I., Schwartz, Thue W., Frimurer, Thomas M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6030209/
https://www.ncbi.nlm.nih.gov/pubmed/29968758
http://dx.doi.org/10.1038/s41598-018-28263-7
_version_ 1783337100185174016
author Rexen Ulven, Elisabeth
Trauelsen, Mette
Brvar, Matjaz
Lückmann, Michael
Bielefeldt, Line Ø.
Jensen, Lisa K. I.
Schwartz, Thue W.
Frimurer, Thomas M.
author_facet Rexen Ulven, Elisabeth
Trauelsen, Mette
Brvar, Matjaz
Lückmann, Michael
Bielefeldt, Line Ø.
Jensen, Lisa K. I.
Schwartz, Thue W.
Frimurer, Thomas M.
author_sort Rexen Ulven, Elisabeth
collection PubMed
description The succinate receptor 1 (SUCNR1) is a receptor for the metabolite succinate, which functions as a metabolic stress signal in the liver, kidney, adipose tissue and the retina. However, potent non-metabolite tool compounds are needed to reveal the physiological role and pharmacological potential of SUCNR1. Recently, we published the discovery of a computationally receptor-structure derived non-metabolite SUCNR1 agonist series with high target selectivity. We here report our structure-activity exploration and optimisation that has resulted in the development of agonists with nanomolar potency and excellent solubility and stability properties in a number of in vitro assays. Ligand-guided receptor models with high discriminative power between binding of active and inactive compounds were developed for design of novel chemotypes.
format Online
Article
Text
id pubmed-6030209
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-60302092018-07-11 Structure-Activity Investigations and Optimisations of Non-metabolite Agonists for the Succinate Receptor 1 Rexen Ulven, Elisabeth Trauelsen, Mette Brvar, Matjaz Lückmann, Michael Bielefeldt, Line Ø. Jensen, Lisa K. I. Schwartz, Thue W. Frimurer, Thomas M. Sci Rep Article The succinate receptor 1 (SUCNR1) is a receptor for the metabolite succinate, which functions as a metabolic stress signal in the liver, kidney, adipose tissue and the retina. However, potent non-metabolite tool compounds are needed to reveal the physiological role and pharmacological potential of SUCNR1. Recently, we published the discovery of a computationally receptor-structure derived non-metabolite SUCNR1 agonist series with high target selectivity. We here report our structure-activity exploration and optimisation that has resulted in the development of agonists with nanomolar potency and excellent solubility and stability properties in a number of in vitro assays. Ligand-guided receptor models with high discriminative power between binding of active and inactive compounds were developed for design of novel chemotypes. Nature Publishing Group UK 2018-07-03 /pmc/articles/PMC6030209/ /pubmed/29968758 http://dx.doi.org/10.1038/s41598-018-28263-7 Text en © The Author(s) 2018 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
spellingShingle Article
Rexen Ulven, Elisabeth
Trauelsen, Mette
Brvar, Matjaz
Lückmann, Michael
Bielefeldt, Line Ø.
Jensen, Lisa K. I.
Schwartz, Thue W.
Frimurer, Thomas M.
Structure-Activity Investigations and Optimisations of Non-metabolite Agonists for the Succinate Receptor 1
title Structure-Activity Investigations and Optimisations of Non-metabolite Agonists for the Succinate Receptor 1
title_full Structure-Activity Investigations and Optimisations of Non-metabolite Agonists for the Succinate Receptor 1
title_fullStr Structure-Activity Investigations and Optimisations of Non-metabolite Agonists for the Succinate Receptor 1
title_full_unstemmed Structure-Activity Investigations and Optimisations of Non-metabolite Agonists for the Succinate Receptor 1
title_short Structure-Activity Investigations and Optimisations of Non-metabolite Agonists for the Succinate Receptor 1
title_sort structure-activity investigations and optimisations of non-metabolite agonists for the succinate receptor 1
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6030209/
https://www.ncbi.nlm.nih.gov/pubmed/29968758
http://dx.doi.org/10.1038/s41598-018-28263-7
work_keys_str_mv AT rexenulvenelisabeth structureactivityinvestigationsandoptimisationsofnonmetaboliteagonistsforthesuccinatereceptor1
AT trauelsenmette structureactivityinvestigationsandoptimisationsofnonmetaboliteagonistsforthesuccinatereceptor1
AT brvarmatjaz structureactivityinvestigationsandoptimisationsofnonmetaboliteagonistsforthesuccinatereceptor1
AT luckmannmichael structureactivityinvestigationsandoptimisationsofnonmetaboliteagonistsforthesuccinatereceptor1
AT bielefeldtlineø structureactivityinvestigationsandoptimisationsofnonmetaboliteagonistsforthesuccinatereceptor1
AT jensenlisaki structureactivityinvestigationsandoptimisationsofnonmetaboliteagonistsforthesuccinatereceptor1
AT schwartzthuew structureactivityinvestigationsandoptimisationsofnonmetaboliteagonistsforthesuccinatereceptor1
AT frimurerthomasm structureactivityinvestigationsandoptimisationsofnonmetaboliteagonistsforthesuccinatereceptor1